These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36860172)

  • 21. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features.
    Brady S; Squier W; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers.
    Buzkova J; Nikkanen J; Ahola S; Hakonen AH; Sevastianova K; Hovinen T; Yki-Järvinen H; Pietiläinen KH; Lönnqvist T; Velagapudi V; Carroll CJ; Suomalainen A
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30373890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis.
    Lucchini M; De Arcangelis V; Santoro M; Morosetti R; Broccolini A; Mirabella M
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
    Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.
    Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE
    Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion Body Myositis.
    Goyal NA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings.
    Pinto MV; Laughlin RS; Klein CJ; Mandrekar J; Naddaf E
    Rheumatology (Oxford); 2022 May; 61(6):2504-2511. PubMed ID: 34617994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
    Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
    Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Neurol Clin; 2014 Aug; 32(3):629-46, vii. PubMed ID: 25037082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sporadic Inclusion Body Myositis: A Clinicopathological Study.
    Challa S; Jakati S; Narla S; Uppin MS; Kannan MA; Jagarlapudi MKM
    Neurol India; 2021; 69(3):638-641. PubMed ID: 34169859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.
    Nelke C; Schroeter CB; Theissen L; Preusse C; Pawlitzki M; Räuber S; Dobelmann V; Cengiz D; Kleefeld F; Roos A; Schoser B; Brunn A; Neuen-Jacob E; Zschüntzsch J; Meuth SG; Stenzel W; Ruck T
    Acta Neuropathol; 2023 Nov; 146(5):725-745. PubMed ID: 37773216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
    Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
    Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.
    Joshi PR; Vetterke M; Hauburger A; Tacik P; Stoltenburg G; Hanisch F
    J Clin Neurosci; 2014 Nov; 21(11):1959-63. PubMed ID: 25311418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion body myositis in twins.
    Amato AA; Shebert RT
    Neurology; 1998 Aug; 51(2):598-600. PubMed ID: 9710045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison.
    Lindberg C; Borg K; Edström L; Hedström A; Oldfors A
    J Neurol Sci; 1991 May; 103(1):76-81. PubMed ID: 1650819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inclusion body myositis.
    Dimachkie MM; Barohn RJ
    Curr Neurol Neurosci Rep; 2013 Jan; 13(1):321. PubMed ID: 23250766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy.
    Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A
    Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion body myositis: a case of bilateral extremity weakness.
    Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK
    Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.
    De Paepe B
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30621041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.